PRINCIPAL SECURITIES, INC.
Broker-DealerPosition in TAK — Takeda Pharmaceutical Co Ltd
CIK 12600
DES MOINES, IA
Position in TAK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$162,944
+$86,407 QoQ
Shares Held
10,165
+94.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#232
of 375 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRINCIPAL SECURITIES, INC. holds $4,721,012 across 6 Drug Manufacturers - Specialty & Generic names. TAK ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
24,523 | $1,762,222 | |
| 2 | HLN |
Haleon plc
|
148,878 | $1,389,031 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
910 | $493,065 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
2,887 | $486,574 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
24,678 | $427,176 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
10,165 | $162,944 |
All Filings in TAK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $162,944 | 10,165 | Shares | Sole | 2026-08-04 | |
| 2025-09-30 | $76,537 | 5,228 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $71,641 | 4,634 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $57,487 | 3,866 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $51,185 | 3,866 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $45,902 | 3,228 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $36,646 | 2,832 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $38,558 | 2,776 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $28,240 | 1,979 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||